FIRST ON THE DAILY SIGNAL—The emergency room visitation rate for abortion complications appears to have increased since the U.S. Food and Drug Administration removed guardrails on the use of the abortion pill.
A U.S. federal court on July 13, 2020, temporarily stopped the FDA from requiring that mifepristone, or the abortion pill, be dispensed in person. That injunction remained in place until it was temporarily reversed by the U.S. Supreme Court in January 2021.
In April 2021, the FDA again stopped requiring that abortion drugs be dispensed to mothers in person, which allowed women to receive them through telehealth appointments and by mail. The FDA has not enforced the in-person dispensing requirement ever since.
There’s now evidence that the FDA’s change in the restrictions for mifepristone since 2020 have increased the hospital emergency room visitation rate….
